Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine.
Döhner H, Pratz KW, DiNardo CD, Wei AH, Jonas BA, Pullarkat V, Thirman MJ, Récher C, Schuh AC, Babu S, Li X, Ku G, Liu Z, Sun Y, Potluri J, Dail M, Chyla B, Pollyea DA.
Döhner H, et al. Among authors: schuh ac.
Blood. 2024 Aug 12:blood.2024024944. doi: 10.1182/blood.2024024944. Online ahead of print.
Blood. 2024.
PMID: 39133921